Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy
Tilo Thottakara, Natalie Lund, Elisabeth Krämer, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1718-1718
Open Access | Times Cited: 24

Showing 24 citing articles:

Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 52
miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives
Francesco Sessa, Monica Salerno, Massimiliano Esposito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5192-5192
Open Access | Times Cited: 35
Targeting miRNA with flavonoids: unlocking novel pathways in cardiovascular disease management
Arya Tjipta Prananda, Princella Halim, Rony Abdi Syahputra
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Detection of myocardial fibrosis: Where we stand
Leyi Zhu, Yining Wang, Shihua Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 28
New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies
Yuanyuan Zhao, Dunfeng Du, Shanshan Chen, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1390-1390
Open Access | Times Cited: 25
A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research
Cameron Brown, Michael D. Mantzaris, Elpiniki Nicolaou, et al.
Cardio-Oncology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 21
MicroRNA-499a in heart diseases: prospects for use in diagnostics. A review
Maria Pisklova, Natalia Baulina, Ivan Kiselev, et al.
Terapevticheskii arkhiv (2025) Vol. 97, Iss. 04, pp. 353-359
Open Access
Small extracellular vesicles associated miRNA in myocardial fibrosis
Minwen Long, Min Cheng
Biochemical and Biophysical Research Communications (2024) Vol. 727, pp. 150336-150336
Open Access | Times Cited: 3
CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p
Bin Yu, Yi Wang, Jun‐O Jin, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 3
Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy
Natalia Baulina, Maria Pisklova, Ivan Kiselev, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3791-3791
Open Access | Times Cited: 14
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers
Fanyan Luo, Wei Liu, Haisong Bu
Heart Failure Reviews (2022) Vol. 27, Iss. 6, pp. 2211-2221
Closed Access | Times Cited: 12
Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face
Yssel Mendoza‐Marí, Marcel Fraix, Devendra K. Agrawal
Archives of Internal Medicine Research (2024) Vol. 07, Iss. 01
Open Access | Times Cited: 2
Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
Chen Zhang, Hongbo Zhang, Lei Zhao, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1978-1978
Open Access | Times Cited: 9
miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant Pathways
Laura Sabater, J Gossart, Inmaculada Hernández, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 4, pp. 417-429
Open Access | Times Cited: 5
MicroRNAs and cardiac fibrosis: A comprehensive update on mechanisms and consequences
Zekihan Gocer, Alperen Elek, Halil Caska, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154853-154853
Closed Access | Times Cited: 4
Sevoflurane attenuates hypoxia/reoxygenation-induced cardiomyocyte injury by regulating miR-4454
J.Q. Chen, G Q Zhang, Aiping Guo, et al.
Toxicology Research (2024) Vol. 13, Iss. 6
Closed Access | Times Cited: 1
Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy
Lanyan Guo, Yue Cai, Bo Wang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
Raza Abbas Syed, Matthew G. Davey, Vinitha Richard, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12694-12694
Open Access | Times Cited: 3
Regulatory Potential of Noncoding RNAs Co-Located with Cardiomyopathy Related Genes
А. Н. Кучер, М. С. Назаренко
Russian Journal of Genetics (2023) Vol. 59, Iss. 4, pp. 325-343
Closed Access | Times Cited: 3
Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling
Irina Zalivina, Temo Barwari, Xiaoke Yin, et al.
Journal of Molecular and Cellular Cardiology Plus (2023) Vol. 6, pp. 100056-100056
Open Access | Times Cited: 3
Noncoding RNAs and Cardiac Fibrosis
WU Chang-yong, Suli Bao, Ruijie Li, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 2, pp. 63-63
Open Access | Times Cited: 2
Regulatory Potential of Non-Coding RNAs Colocalized with Cardiomyopathy-Related Genes
А. Н. Кучер, М. С. Назаренко
Генетика (2023) Vol. 59, Iss. 4, pp. 381-402
Closed Access | Times Cited: 1
Assessment of NanoString technology as a tool for profiling circulating miRNA in maternal blood during pregnancy
Petra Adamova, Andrew K. Powell, Iain M. Dykes
Extracellular Vesicles and Circulating Nucleic Acids (2024)
Open Access
Exercise mediates noncoding RNAs in cardiovascular diseases: pathophysiological roles and clinical application
Changyong Wu, X. Chen, Lu Yang, et al.
Expert Reviews in Molecular Medicine (2024) Vol. 27
Open Access
Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?
О. С. Чумакова, Е. А. Мершина
Experimental Biology and Medicine (2024) Vol. 249
Open Access
Page 1

Scroll to top